Morgan Stanley Maintains Overweight on Corpay, Raises Price Target to $415

Benzinga · 1d ago
Morgan Stanley analyst Michael Infante maintains Corpay (NYSE:CPAY) with a Overweight and raises the price target from $400 to $415.